Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromhexine hydrochloride versus placebo for clinical outcomes in hospitalized adults with COVID-19
IRCT20200818048444N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bromhexine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: ICU transfer, Intubation and mechanical ventilation and 1 more. Started Nov 2020; status: completed.
02
Drugs
bromhexine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200818048444N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200818048444N2.